Pembrolizumab in adjuvant therapy in non-small cell lung cancers
Bull Cancer. 2024 Mar 11:S0007-4551(24)00047-X. doi: 10.1016/j.bulcan.2023.12.012. Online ahead of print.NO ABSTRACTPMID:38471995 | DOI:10.1016/j.bulcan.2023.12.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Antoine Lef èvre Claire Tissot Source Type: research

Pembrolizumab+chemotherapy as first-line treatment in patients with HER negative advanced oesogastric adenocarcinoma
Bull Cancer. 2024 Mar 7:S0007-4551(24)00072-9. doi: 10.1016/j.bulcan.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38458924 | DOI:10.1016/j.bulcan.2024.01.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Martin Duval Aziz Zaanan Source Type: research

Talquetamab  - multiple myeloma after at least three prior lines of therapy
Bull Cancer. 2024 Mar 7:S0007-4551(24)00049-3. doi: 10.1016/j.bulcan.2023.12.014. Online ahead of print.NO ABSTRACTPMID:38458925 | DOI:10.1016/j.bulcan.2023.12.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Thomas Fatrara Emilie Chalayer Source Type: research

Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer
Bull Cancer. 2024 Mar 7:S0007-4551(24)00046-8. doi: 10.1016/j.bulcan.2023.12.011. Online ahead of print.NO ABSTRACTPMID:38458926 | DOI:10.1016/j.bulcan.2023.12.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Hanna Besnainou Luc Cabel Source Type: research

PAL-PRAT study: Healthcare workers' knowledge and perception of palliative practices in a Cancer Center
DISCUSSION: This survey underlines the importance of training and support for the professionals caring for patients in palliative situation and their relatives in France.PMID:38458927 | DOI:10.1016/j.bulcan.2023.12.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Marie Locatelli C écile Flahault Nicolas Roche Christine Mateus Fran çois Blot None Lucile Montalescot Jean-Bernard Le Provost L éonor Fasse Source Type: research

Barriers and facilitators to physical activity in oncology in Seine-Saint-Denis: A qualitative study using the socio-ecological approach
DISCUSSION: A diversity of representations, combinations of factors, and experiences are described. Getting people with cancer to engage in and maintain long-term physical activity is a complex task, requiring multidisciplinary action on all socio-ecological factors.PMID:38458928 | DOI:10.1016/j.bulcan.2023.12.017 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: C édric Sarreboubee Albane Aumaitre Lazhar Labiadh Aude-Marie Foucaut Source Type: research

Pembrolizumab+chemotherapy as first-line treatment in patients with HER negative advanced oesogastric adenocarcinoma
Bull Cancer. 2024 Mar 7:S0007-4551(24)00072-9. doi: 10.1016/j.bulcan.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38458924 | DOI:10.1016/j.bulcan.2024.01.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Martin Duval Aziz Zaanan Source Type: research

Talquetamab  - multiple myeloma after at least three prior lines of therapy
Bull Cancer. 2024 Mar 7:S0007-4551(24)00049-3. doi: 10.1016/j.bulcan.2023.12.014. Online ahead of print.NO ABSTRACTPMID:38458925 | DOI:10.1016/j.bulcan.2023.12.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Thomas Fatrara Emilie Chalayer Source Type: research

Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer
Bull Cancer. 2024 Mar 7:S0007-4551(24)00046-8. doi: 10.1016/j.bulcan.2023.12.011. Online ahead of print.NO ABSTRACTPMID:38458926 | DOI:10.1016/j.bulcan.2023.12.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Hanna Besnainou Luc Cabel Source Type: research

PAL-PRAT study: Healthcare workers' knowledge and perception of palliative practices in a Cancer Center
DISCUSSION: This survey underlines the importance of training and support for the professionals caring for patients in palliative situation and their relatives in France.PMID:38458927 | DOI:10.1016/j.bulcan.2023.12.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Marie Locatelli C écile Flahault Nicolas Roche Christine Mateus Fran çois Blot None Lucile Montalescot Jean-Bernard Le Provost L éonor Fasse Source Type: research

Barriers and facilitators to physical activity in oncology in Seine-Saint-Denis: A qualitative study using the socio-ecological approach
DISCUSSION: A diversity of representations, combinations of factors, and experiences are described. Getting people with cancer to engage in and maintain long-term physical activity is a complex task, requiring multidisciplinary action on all socio-ecological factors.PMID:38458928 | DOI:10.1016/j.bulcan.2023.12.017 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: C édric Sarreboubee Albane Aumaitre Lazhar Labiadh Aude-Marie Foucaut Source Type: research

Pembrolizumab+chemotherapy as first-line treatment in patients with HER negative advanced oesogastric adenocarcinoma
Bull Cancer. 2024 Mar 7:S0007-4551(24)00072-9. doi: 10.1016/j.bulcan.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38458924 | DOI:10.1016/j.bulcan.2024.01.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Martin Duval Aziz Zaanan Source Type: research

Talquetamab  - multiple myeloma after at least three prior lines of therapy
Bull Cancer. 2024 Mar 7:S0007-4551(24)00049-3. doi: 10.1016/j.bulcan.2023.12.014. Online ahead of print.NO ABSTRACTPMID:38458925 | DOI:10.1016/j.bulcan.2023.12.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Thomas Fatrara Emilie Chalayer Source Type: research

Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer
Bull Cancer. 2024 Mar 7:S0007-4551(24)00046-8. doi: 10.1016/j.bulcan.2023.12.011. Online ahead of print.NO ABSTRACTPMID:38458926 | DOI:10.1016/j.bulcan.2023.12.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Hanna Besnainou Luc Cabel Source Type: research

PAL-PRAT study: Healthcare workers' knowledge and perception of palliative practices in a Cancer Center
DISCUSSION: This survey underlines the importance of training and support for the professionals caring for patients in palliative situation and their relatives in France.PMID:38458927 | DOI:10.1016/j.bulcan.2023.12.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Marie Locatelli C écile Flahault Nicolas Roche Christine Mateus Fran çois Blot None Lucile Montalescot Jean-Bernard Le Provost L éonor Fasse Source Type: research